- published: 22 Jul 2016
- views: 1331
Create your page here
-
remove the playlistPharmaceutical Sources
-
remove the playlistLatest Videos
-
remove the playlistLongest Videos
- remove the playlistPharmaceutical Sources
- remove the playlistLatest Videos
- remove the playlistLongest Videos
back to playlist
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more.
----------
Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow
Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Thanks Tank Tumblr: http://thankstank.tumblr.com
Sources:
http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm
http://news.stanford.edu/pr/01/khosla37.html
http://www.sciencedaily.com/releases/2014/07/140710141351.htm
http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html
http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/
http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/
http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx
http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections
http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html
http://www.sciencedaily.com/releases/2010/09/100906202901.htm
http://www.wired.com/2010/09/cockroach-brains/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/
http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html
http://www.medicalnewstoday.com/articles/103400.php
http://www.nature.com/nri/journal/v8/n5/full/nri2333.html
http://www.sciencedaily.com/releases/2008/04/080407074556.htm
http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/
http://myfwc.com/wildlifehabitats/managed/alligator/facts/
http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html
http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1
http://mcdermott.opt.uh.edu/research2.html
http://www.sciencedaily.com/releases/2012/04/120411205423.htm
http://www.bbc.com/news/uk-scotland-scotland-business-19150324
http://www.bbc.com/news/health-19520629
http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/
http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004
http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria
http://www.medicalnewstoday.com/articles/256416.php
http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html
http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/
- published: 21 Nov 2014
- views: 851309
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals.
Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
- published: 02 Jul 2012
- views: 429
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
- published: 22 Jun 2012
- views: 130
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis.
Peak Nootropics
http://peaknootropics.com/?affiliates=63
New Star Nootropics
https://newstarnootropics.com/
PowderCity.com
http://powdercity.refr.cc/X2RV8NS
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 17 Oct 2014
- views: 1125
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 24 Mar 2016
- views: 72
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217
http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut
https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/
https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf
http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten
http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html
https://www.youtube.com/watch?v=P3gBV6HjBRU
http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf
http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672
hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch
http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html
http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE
- published: 30 Apr 2017
- views: 98
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute.
Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation.
The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute.
Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com.
- published: 19 Jun 2015
- views: 3829
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016.
Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/
https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
- published: 26 Sep 2016
- views: 17203
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 02 Nov 2015
- views: 41
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 26 Nov 2016
- views: 83
Pharmaceutical industry
The pharmaceutical industry develops, produces, and markets drugs or pharmaceuticals for use as medications. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy and marketing of drugs.
History
Mid-1800s – 1945: From botanicals to the first synthetic drugs
The modern pharmaceutical industry traces its roots to two sources. The first of these were local apothecaries that expanded from their traditional role distributing botanical drugs such as morphine and quinine to wholesale manufacture in the mid 1800s. Rational drug discovery from plants started particularly with the isolation of morphine, analgesic and sleep-inducing agent from opium, by the German apothecary assistant Friedrich Sertürner, who named the compound after the Greek god of dreams, Morpheus. Multinational corporations including Merck, Hoffman-La Roche, Burroughs-Wellcome (now part of Glaxo Smith Kline), Abbott Laboratories, Eli Lilly and Upjohn (now part of Pfizer) began as local apothecary shops in the mid-1800s. By the late 1880s, German dye manufacturers had perfected the purification of individual organic compounds from coal tar and other mineral sources and had also established rudimentary methods in organic chemical synthesis. The development of synthetic chemical methods allowed scientists to systematically vary the structure of chemical substances, and growth in the emerging science of pharmacology expanded their ability to evaluate the biological effects of these structural changes.
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Pharmaceutical_industry
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
Adam Ruins Everything
Adam Ruins Everything is a sketch comedy/educational television show starring Adam Conover that debuted on September 29, 2015 on truTV. On January 7, 2016, it was announced that the show had been picked up for a 14 additional episodes to air starting in August 2016. The series aims to shine light on popular false impressions and trends, debunking false ideas in society.
Synopsis
Adam Ruins Everything is based on a CollegeHumor web series of the same name, and stars comedian Adam Conover (who was also the star of the CollegeHumor series) as the host. In the show, Conover debunks misconceptions with what the show calls "annoying facts", backing up his points by lecturing the audience, appearing in skits, interviewing experts, and citing references on-screen. Adam has said on a Twitch.tv stream that DVDs could potentially be released.
Episodes
External links
References
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Adam_Ruins_Everything
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
Last Week Tonight with John Oliver
Last Week Tonight with John Oliver, often abridged as Last Week Tonight, is an American late-night talk and news satire television program airing on Sundays on HBO in the United States and HBO Canada, and on Mondays (originally Tuesdays) on Sky Atlantic in the United Kingdom. The half-hour long show premiered on Sunday, April 27, 2014, and is hosted by comedian John Oliver. Last Week Tonight shares some similarities with Comedy Central's The Daily Show with Jon Stewart, where Oliver was previously featured as a correspondent and fill-in host, as it takes a satirical look at news, politics and current events on a weekly basis.
Oliver has said that he has full creative freedom, including free rein to criticize corporations. His initial contract with HBO was for two years with an option for extension. In February 2015, it was announced that the show has been renewed for two additional seasons of 35 episodes each. Oliver and HBO programming president Michael Lombardo have discussed extending the show from half an hour to a full hour and airing more than once a week after Oliver "gets his feet under him".
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Last_Week_Tonight_with_John_Oliver
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
Big Pharma
Big Pharma may refer to:
See also
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Big_Pharma
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
9:47Pharmaceutical Impurities I
Pharmaceutical Impurities IPharmaceutical Impurities I
Introduction, classification and sources of impurities -
8:33Cockroaches, Alligators & Other Weird Sources of New Drugs
Cockroaches, Alligators & Other Weird Sources of New DrugsCockroaches, Alligators & Other Weird Sources of New Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more. ---------- Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Thanks Tank Tumblr: http://thankstank.tumblr.com Sources: http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm http://news.stanford.edu/pr/01/khosla37.html http://www.sciencedaily.com/releases/2014/07/140710141351.htm http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/ http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/ http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html http://www.sciencedaily.com/releases/2010/09/100906202901.htm http://www.wired.com/2010/09/cockroach-brains/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/ http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html http://www.medicalnewstoday.com/articles/103400.php http://www.nature.com/nri/journal/v8/n5/full/nri2333.html http://www.sciencedaily.com/releases/2008/04/080407074556.htm http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/ http://myfwc.com/wildlifehabitats/managed/alligator/facts/ http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1 http://mcdermott.opt.uh.edu/research2.html http://www.sciencedaily.com/releases/2012/04/120411205423.htm http://www.bbc.com/news/uk-scotland-scotland-business-19150324 http://www.bbc.com/news/health-19520629 http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/ http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004 http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria http://www.medicalnewstoday.com/articles/256416.php http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/ -
4:48PILLS - Pharmaceutical Input and Elimination from Local Sources
PILLS - Pharmaceutical Input and Elimination from Local SourcesPILLS - Pharmaceutical Input and Elimination from Local Sources
http://www.pills-project.eu Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals. Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed. -
3:27PILLS Pharmaceutical input and Elimination from local sources.mp4
PILLS Pharmaceutical input and Elimination from local sources.mp4PILLS Pharmaceutical input and Elimination from local sources.mp4
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics. -
13:48Pharmaceutical Impurities II
Pharmaceutical Impurities IIPharmaceutical Impurities II
Sources of impurity -
9:48Sources of Pharmaceutical Grade Racetams
Sources of Pharmaceutical Grade RacetamsSources of Pharmaceutical Grade Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis. Peak Nootropics http://peaknootropics.com/?affiliates=63 New Star Nootropics https://newstarnootropics.com/ PowderCity.com http://powdercity.refr.cc/X2RV8NS on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland -
27:20Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified SourcesWhy Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks. Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland -
8:18The Globalization of Pharmaceutical Industries
The Globalization of Pharmaceutical IndustriesThe Globalization of Pharmaceutical Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to. sources: http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217 http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/ https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html https://www.youtube.com/watch?v=P3gBV6HjBRU http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672 hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE -
2:36Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation TechnologiesPharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute. Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation. The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute. Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com. -
5:53These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
These 13 Corporations Are "Big Pharma": Their History, Crimes, and ProductsThese 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/ This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016. Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/ https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit -
2:01Kissei Pharmaceutical
Kissei PharmaceuticalKissei Pharmaceutical
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances. Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein. DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements. EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness. FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com . Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein. Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade. COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner . Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article. If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email: company@whyinvestin.com -
2:01Ultragenyx Pharmaceutical
Ultragenyx PharmaceuticalUltragenyx Pharmaceutical
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances. Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein. DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements. EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness. FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com . Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein. Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade. COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner . Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article. If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email: company@whyinvestin.com -
0:36Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
In particular the research and analysis discuss revenue prospects, including forecasts to 2025 for prominent companies. That report also analyses the operational performance and forecast profitability of some leading CMOs. The new investigation also discusses forces driving and restraining individual firms and provides competitive intelligence for companies offering pharmaceutical contract manufacturing services. That work also examines opportunities and challenges for organisations and strategies that can be employed to maximise sales performance from 2015. The content of each company profile varies, depending on the breadth of the service portfolio of the company, as well as the availability of information from primary and secondary sources. Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare. Together those studies cover pharmaceuticals, medical devices, diagnostics, national markets, biotechnologies and outsourced services. For an Executive Summary of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://goo.gl/4hw1LW -
1:11:17Pharmaceutical statistics - data sharing
Pharmaceutical statistics - data sharingPharmaceutical statistics - data sharing
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisaged Sara Hughes VP & Head, Clinical Statistics, GSK This talk will begin by outlining the data transparency journey one pharmaceutical company, GSK, has taken over the past few years, including a summary of the current approach to data sharing as well as the method, with rationale, for data anonymisation. The talk will then move on to review some of the known challenges with data sharing, such as the level of data anonymisation required; limitations of anonymisation; data completeness and associated documentation for very old clinical trials; clinical trials with multiple analysis cutpoints over many years; and pooling data across sponsors with different data standards. Some recommendations for how to address these challenges will be discussed. Data Sharing: a young statistician's perspective Sarah Nolan Research Assistant, University of Liverpool I will describe the activities of a young academic researcher in the context of clinical trial data analysis the importance of data access and data transparency in evidence based medicine. I will share my personal experiences of four years of data requesting from multiple sources (academia, government and industry) for a large project in Epilepsy and the use of clinicalstudydatarequest.com and remote data access systems. I will describe the challenges throughout the project, the benefit data sharing initiatives have had for the project and the challenges which remain.
-
Pharmaceutical Impurities I
Introduction, classification and sources of impurities
published: 22 Jul 2016 -
Cockroaches, Alligators & Other Weird Sources of New Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more. ---------- Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Thanks Tank Tumblr: http://thankstan...
published: 21 Nov 2014 -
PILLS - Pharmaceutical Input and Elimination from Local Sources
http://www.pills-project.eu Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals. Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
published: 02 Jul 2012 -
PILLS Pharmaceutical input and Elimination from local sources.mp4
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
published: 22 Jun 2012 -
Pharmaceutical Impurities II
Sources of impurity
published: 22 Jul 2016 -
Sources of Pharmaceutical Grade Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis. Peak Nootropics http://peaknootropics.com/?affiliates=63 New Star Nootropics https://newstarnootropics.com/ PowderCity.com http://powdercity.refr.cc/X2RV8NS on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland
published: 17 Oct 2014 -
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks. Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland
published: 24 Mar 2016 -
The Globalization of Pharmaceutical Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to. sources: http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217 http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/ https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html https://www.youtube.com/watch?v=P3gBV6HjBRU http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf http://...
published: 30 Apr 2017 -
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute. Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler ...
published: 19 Jun 2015 -
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/ This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016. Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/ https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
published: 26 Sep 2016 -
Kissei Pharmaceutical
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS...
published: 02 Nov 2015 -
Ultragenyx Pharmaceutical
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER ...
published: 26 Nov 2016 -
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
In particular the research and analysis discuss revenue prospects, including forecasts to 2025 for prominent companies. That report also analyses the operational performance and forecast profitability of some leading CMOs. The new investigation also discusses forces driving and restraining individual firms and provides competitive intelligence for companies offering pharmaceutical contract manufacturing services. That work also examines opportunities and challenges for organisations and strategies that can be employed to maximise sales performance from 2015. The content of each company profile varies, depending on the breadth of the service portfolio of the company, as well as the availability of information from primary and secondary sources. Top 30 Pharmaceutical Contract Manufacturing...
published: 29 Apr 2016 -
Pharmaceutical statistics - data sharing
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisaged Sara Hughes VP & Head, Clinical Statistics, GSK This talk will begin by outlining the data transparency journey one pharmaceutical company, GSK, has taken over the past few years, including a summary of the current approach to data sharing as well as the method, with rationale, for data anonymisation. The talk will then move on to review some of the known challenges with data sharing, such as the level of data anonymisation required; limitations of anonymisation; data completeness and associated documentation for very old clinical trials; clinical trials with multiple analysis cutpoints over many years; and pooling data across sponsors with different data standards. Some recommendations for how ...
published: 07 Mar 2016 -
Pharmaceutical Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs. Sources: http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
published: 26 Nov 2014 -
Consumerism of the Pharmaceutical Industry
Our teacher asked us to discuss a facet of consumerism. I chose the Pharmaceutical Industry as my topic. Sources: http://www.dailymail.co.uk/health/article-1302035/Unbeatable-NDM-1-enzyme-make-bacterial-diseases-superbugs.html www.sciencedaily.com/releases/2008/01/080105140107.htm "The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States" http://www.washingtontimes.com/news/2010/aug/25/mexico-beginning-crackdown-on-antibiotic-sales/print/ http://www.thepharmaletter.com/file/99248/brazil-to-stop-sales-of-antibiotics-without-prescription.html http://www.ngpharma.com/article/Superbugs-require-new-drugs---antibiotic-resistance/ http://www.ucsusa.org/food_and_agriculture/solutions/wise_antibiotics/ucs-urges-congress-to-adopt.html http://ww...
published: 30 Nov 2010
Pharmaceutical Impurities I
- Order: Reorder
- Duration: 9:47
- Updated: 22 Jul 2016
- views: 1331
Introduction, classification and sources of impurities
Introduction, classification and sources of impurities
https://wn.com/Pharmaceutical_Impurities_I
Cockroaches, Alligators & Other Weird Sources of New Drugs
- Order: Reorder
- Duration: 8:33
- Updated: 21 Nov 2014
- views: 851309
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to comba...
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more.
----------
Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow
Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Thanks Tank Tumblr: http://thankstank.tumblr.com
Sources:
http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm
http://news.stanford.edu/pr/01/khosla37.html
http://www.sciencedaily.com/releases/2014/07/140710141351.htm
http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html
http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/
http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/
http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx
http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections
http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html
http://www.sciencedaily.com/releases/2010/09/100906202901.htm
http://www.wired.com/2010/09/cockroach-brains/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/
http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html
http://www.medicalnewstoday.com/articles/103400.php
http://www.nature.com/nri/journal/v8/n5/full/nri2333.html
http://www.sciencedaily.com/releases/2008/04/080407074556.htm
http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/
http://myfwc.com/wildlifehabitats/managed/alligator/facts/
http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html
http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1
http://mcdermott.opt.uh.edu/research2.html
http://www.sciencedaily.com/releases/2012/04/120411205423.htm
http://www.bbc.com/news/uk-scotland-scotland-business-19150324
http://www.bbc.com/news/health-19520629
http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/
http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004
http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria
http://www.medicalnewstoday.com/articles/256416.php
http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html
http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/
https://wn.com/Cockroaches,_Alligators_Other_Weird_Sources_Of_New_Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more.
----------
Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow
Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Thanks Tank Tumblr: http://thankstank.tumblr.com
Sources:
http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm
http://news.stanford.edu/pr/01/khosla37.html
http://www.sciencedaily.com/releases/2014/07/140710141351.htm
http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html
http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/
http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/
http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx
http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections
http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html
http://www.sciencedaily.com/releases/2010/09/100906202901.htm
http://www.wired.com/2010/09/cockroach-brains/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/
http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html
http://www.medicalnewstoday.com/articles/103400.php
http://www.nature.com/nri/journal/v8/n5/full/nri2333.html
http://www.sciencedaily.com/releases/2008/04/080407074556.htm
http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/
http://myfwc.com/wildlifehabitats/managed/alligator/facts/
http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html
http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1
http://mcdermott.opt.uh.edu/research2.html
http://www.sciencedaily.com/releases/2012/04/120411205423.htm
http://www.bbc.com/news/uk-scotland-scotland-business-19150324
http://www.bbc.com/news/health-19520629
http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/
http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004
http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria
http://www.medicalnewstoday.com/articles/256416.php
http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html
http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/
- published: 21 Nov 2014
- views: 851309
PILLS - Pharmaceutical Input and Elimination from Local Sources
- Order: Reorder
- Duration: 4:48
- Updated: 02 Jul 2012
- views: 429
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle a...
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals.
Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
https://wn.com/Pills_Pharmaceutical_Input_And_Elimination_From_Local_Sources
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals.
Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
- published: 02 Jul 2012
- views: 429
PILLS Pharmaceutical input and Elimination from local sources.mp4
- Order: Reorder
- Duration: 3:27
- Updated: 22 Jun 2012
- views: 130
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst...
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
https://wn.com/Pills_Pharmaceutical_Input_And_Elimination_From_Local_Sources.Mp4
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
- published: 22 Jun 2012
- views: 130
Pharmaceutical Impurities II
- Order: Reorder
- Duration: 13:48
- Updated: 22 Jul 2016
- views: 1232
Sources of impurity
Sources of impurity
https://wn.com/Pharmaceutical_Impurities_Ii
Sources of impurity
- published: 22 Jul 2016
- views: 1232
Sources of Pharmaceutical Grade Racetams
- Order: Reorder
- Duration: 9:48
- Updated: 17 Oct 2014
- views: 1125
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd pa...
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis.
Peak Nootropics
http://peaknootropics.com/?affiliates=63
New Star Nootropics
https://newstarnootropics.com/
PowderCity.com
http://powdercity.refr.cc/X2RV8NS
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
https://wn.com/Sources_Of_Pharmaceutical_Grade_Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis.
Peak Nootropics
http://peaknootropics.com/?affiliates=63
New Star Nootropics
https://newstarnootropics.com/
PowderCity.com
http://powdercity.refr.cc/X2RV8NS
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 17 Oct 2014
- views: 1125
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Order: Reorder
- Duration: 27:20
- Updated: 24 Mar 2016
- views: 72
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free m...
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
https://wn.com/Why_Choose_Pharmaceutical_Grade_Nootropics_3Rd_Party_Verified_Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 24 Mar 2016
- views: 72
The Globalization of Pharmaceutical Industries
- Order: Reorder
- Duration: 8:18
- Updated: 30 Apr 2017
- views: 98
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-ko...
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217
http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut
https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/
https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf
http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten
http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html
https://www.youtube.com/watch?v=P3gBV6HjBRU
http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf
http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672
hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch
http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html
http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE
https://wn.com/The_Globalization_Of_Pharmaceutical_Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217
http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut
https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/
https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf
http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten
http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html
https://www.youtube.com/watch?v=P3gBV6HjBRU
http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf
http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672
hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch
http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html
http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE
- published: 30 Apr 2017
- views: 98
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
- Order: Reorder
- Duration: 2:36
- Updated: 19 Jun 2015
- views: 3829
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Auto...
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute.
Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation.
The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute.
Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com.
https://wn.com/Pharmaceutical_Cartoning_System_With_Robotic_Pick_Place_Trans_Automation_Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute.
Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation.
The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute.
Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com.
- published: 19 Jun 2015
- views: 3829
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
- Order: Reorder
- Duration: 5:53
- Updated: 26 Sep 2016
- views: 17203
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insigh...
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016.
Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/
https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
https://wn.com/These_13_Corporations_Are_Big_Pharma_Their_History,_Crimes,_And_Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016.
Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/
https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
- published: 26 Sep 2016
- views: 17203
Kissei Pharmaceutical
- Order: Reorder
- Duration: 2:01
- Updated: 02 Nov 2015
- views: 41
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securit...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
https://wn.com/Kissei_Pharmaceutical
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 02 Nov 2015
- views: 41
Ultragenyx Pharmaceutical
- Order: Reorder
- Duration: 2:01
- Updated: 26 Nov 2016
- views: 83
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global secur...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
https://wn.com/Ultragenyx_Pharmaceutical
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 26 Nov 2016
- views: 83
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
- Order: Reorder
- Duration: 0:36
- Updated: 29 Apr 2016
- views: 86
In particular the research and analysis discuss revenue prospects, including forecasts to 2025 for prominent companies. That report also analyses the operationa...
In particular the research and analysis discuss revenue prospects, including forecasts to 2025 for prominent companies. That report also analyses the operational performance and forecast profitability of some leading CMOs. The new investigation also discusses forces driving and restraining individual firms and provides competitive intelligence for companies offering pharmaceutical contract manufacturing services. That work also examines opportunities and challenges for organisations and strategies that can be employed to maximise sales performance from 2015.
The content of each company profile varies, depending on the breadth of the service portfolio of the company, as well as the availability of information from primary and secondary sources.
Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare. Together those studies cover pharmaceuticals, medical devices, diagnostics, national markets, biotechnologies and outsourced services.
For an Executive Summary of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://goo.gl/4hw1LW
https://wn.com/Pharma_Leader_Series_Top_30_Pharmaceutical_Contract_Manufacturing_Organisations_Cmos_2015_2025
In particular the research and analysis discuss revenue prospects, including forecasts to 2025 for prominent companies. That report also analyses the operational performance and forecast profitability of some leading CMOs. The new investigation also discusses forces driving and restraining individual firms and provides competitive intelligence for companies offering pharmaceutical contract manufacturing services. That work also examines opportunities and challenges for organisations and strategies that can be employed to maximise sales performance from 2015.
The content of each company profile varies, depending on the breadth of the service portfolio of the company, as well as the availability of information from primary and secondary sources.
Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) – Market, Industry, Trends, Technologies and Prospects 2015-2025 adds to visiongain’s range of analytical reports on industries and markets in healthcare. Together those studies cover pharmaceuticals, medical devices, diagnostics, national markets, biotechnologies and outsourced services.
For an Executive Summary of this report please contact sara.peerun@visiongainglobal.com (+44 (0) 20 7336 6100) or refer to our website: https://goo.gl/4hw1LW
- published: 29 Apr 2016
- views: 86
Pharmaceutical statistics - data sharing
- Order: Reorder
- Duration: 1:11:17
- Updated: 07 Mar 2016
- views: 393
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisaged
Sara Hughes
VP & Head, Clinical Statistics, GSK
This talk will b...
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisaged
Sara Hughes
VP & Head, Clinical Statistics, GSK
This talk will begin by outlining the data transparency journey one pharmaceutical company, GSK, has taken over the past few years, including a summary of the current approach to data sharing as well as the method, with rationale, for data anonymisation. The talk will then move on to review some of the known challenges with data sharing, such as the level of data anonymisation required; limitations of anonymisation; data completeness and associated documentation for very old clinical trials; clinical trials with multiple analysis cutpoints over many years; and pooling data across sponsors with different data standards. Some recommendations for how to address these challenges will be discussed.
Data Sharing: a young statistician's perspective
Sarah Nolan
Research Assistant, University of Liverpool
I will describe the activities of a young academic researcher in the context of clinical trial data analysis the importance of data access and data transparency in evidence based medicine. I will share my personal experiences of four years of data requesting from multiple sources (academia, government and industry) for a large project in Epilepsy and the use of clinicalstudydatarequest.com and remote data access systems. I will describe the challenges throughout the project, the benefit data sharing initiatives have had for the project and the challenges which remain.
https://wn.com/Pharmaceutical_Statistics_Data_Sharing
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisaged
Sara Hughes
VP & Head, Clinical Statistics, GSK
This talk will begin by outlining the data transparency journey one pharmaceutical company, GSK, has taken over the past few years, including a summary of the current approach to data sharing as well as the method, with rationale, for data anonymisation. The talk will then move on to review some of the known challenges with data sharing, such as the level of data anonymisation required; limitations of anonymisation; data completeness and associated documentation for very old clinical trials; clinical trials with multiple analysis cutpoints over many years; and pooling data across sponsors with different data standards. Some recommendations for how to address these challenges will be discussed.
Data Sharing: a young statistician's perspective
Sarah Nolan
Research Assistant, University of Liverpool
I will describe the activities of a young academic researcher in the context of clinical trial data analysis the importance of data access and data transparency in evidence based medicine. I will share my personal experiences of four years of data requesting from multiple sources (academia, government and industry) for a large project in Epilepsy and the use of clinicalstudydatarequest.com and remote data access systems. I will describe the challenges throughout the project, the benefit data sharing initiatives have had for the project and the challenges which remain.
- published: 07 Mar 2016
- views: 393
Pharmaceutical Prison
- Order: Reorder
- Duration: 25:12
- Updated: 26 Nov 2014
- views: 544
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural r...
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs.
Sources:
http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
https://wn.com/Pharmaceutical_Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs.
Sources:
http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
- published: 26 Nov 2014
- views: 544
Consumerism of the Pharmaceutical Industry
- Order: Reorder
- Duration: 12:07
- Updated: 30 Nov 2010
- views: 39
Our teacher asked us to discuss a facet of consumerism. I chose the Pharmaceutical Industry as my topic.
Sources:
http://www.dailymail.co.uk/health/article-13...
Our teacher asked us to discuss a facet of consumerism. I chose the Pharmaceutical Industry as my topic.
Sources:
http://www.dailymail.co.uk/health/article-1302035/Unbeatable-NDM-1-enzyme-make-bacterial-diseases-superbugs.html
www.sciencedaily.com/releases/2008/01/080105140107.htm
"The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States"
http://www.washingtontimes.com/news/2010/aug/25/mexico-beginning-crackdown-on-antibiotic-sales/print/
http://www.thepharmaletter.com/file/99248/brazil-to-stop-sales-of-antibiotics-without-prescription.html
http://www.ngpharma.com/article/Superbugs-require-new-drugs---antibiotic-resistance/
http://www.ucsusa.org/food_and_agriculture/solutions/wise_antibiotics/ucs-urges-congress-to-adopt.html
http://www.nature.com/nrd/journal/v9/n9/full/nrd3267.html
http://en.wikipedia.org/wiki/Pharmaceutical_industry
https://wn.com/Consumerism_Of_The_Pharmaceutical_Industry
Our teacher asked us to discuss a facet of consumerism. I chose the Pharmaceutical Industry as my topic.
Sources:
http://www.dailymail.co.uk/health/article-1302035/Unbeatable-NDM-1-enzyme-make-bacterial-diseases-superbugs.html
www.sciencedaily.com/releases/2008/01/080105140107.htm
"The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States"
http://www.washingtontimes.com/news/2010/aug/25/mexico-beginning-crackdown-on-antibiotic-sales/print/
http://www.thepharmaletter.com/file/99248/brazil-to-stop-sales-of-antibiotics-without-prescription.html
http://www.ngpharma.com/article/Superbugs-require-new-drugs---antibiotic-resistance/
http://www.ucsusa.org/food_and_agriculture/solutions/wise_antibiotics/ucs-urges-congress-to-adopt.html
http://www.nature.com/nrd/journal/v9/n9/full/nrd3267.html
http://en.wikipedia.org/wiki/Pharmaceutical_industry
- published: 30 Nov 2010
- views: 39
-
Pharmaceutical Impurities I
Introduction, classification and sources of impurities
published: 22 Jul 2016 -
Cockroaches, Alligators & Other Weird Sources of New Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more. ---------- Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow ---------- Looking for SciShow elsewhere on the internet? Facebook: http://www.facebook.com/scishow Twitter: http://www.twitter.com/scishow Tumblr: http://scishow.tumblr.com Thanks Tank Tumblr: http://thankstan...
published: 21 Nov 2014 -
PILLS - Pharmaceutical Input and Elimination from Local Sources
http://www.pills-project.eu Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals. Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
published: 02 Jul 2012 -
PILLS Pharmaceutical input and Elimination from local sources.mp4
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
published: 22 Jun 2012 -
Pharmaceutical Impurities II
Sources of impurity
published: 22 Jul 2016 -
Sources of Pharmaceutical Grade Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis. Peak Nootropics http://peaknootropics.com/?affiliates=63 New Star Nootropics https://newstarnootropics.com/ PowderCity.com http://powdercity.refr.cc/X2RV8NS on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland
published: 17 Oct 2014 -
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks. Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland
published: 24 Mar 2016 -
The Globalization of Pharmaceutical Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to. sources: http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217 http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/ https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html https://www.youtube.com/watch?v=P3gBV6HjBRU http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf http://...
published: 30 Apr 2017 -
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute. Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler ...
published: 19 Jun 2015 -
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/ This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016. Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/ https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
published: 26 Sep 2016
Pharmaceutical Impurities I
- Order: Reorder
- Duration: 9:47
- Updated: 22 Jul 2016
- views: 1331
Introduction, classification and sources of impurities
Introduction, classification and sources of impurities
https://wn.com/Pharmaceutical_Impurities_I
Cockroaches, Alligators & Other Weird Sources of New Drugs
- Order: Reorder
- Duration: 8:33
- Updated: 21 Nov 2014
- views: 851309
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to comba...
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more.
----------
Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow
Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Thanks Tank Tumblr: http://thankstank.tumblr.com
Sources:
http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm
http://news.stanford.edu/pr/01/khosla37.html
http://www.sciencedaily.com/releases/2014/07/140710141351.htm
http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html
http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/
http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/
http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx
http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections
http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html
http://www.sciencedaily.com/releases/2010/09/100906202901.htm
http://www.wired.com/2010/09/cockroach-brains/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/
http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html
http://www.medicalnewstoday.com/articles/103400.php
http://www.nature.com/nri/journal/v8/n5/full/nri2333.html
http://www.sciencedaily.com/releases/2008/04/080407074556.htm
http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/
http://myfwc.com/wildlifehabitats/managed/alligator/facts/
http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html
http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1
http://mcdermott.opt.uh.edu/research2.html
http://www.sciencedaily.com/releases/2012/04/120411205423.htm
http://www.bbc.com/news/uk-scotland-scotland-business-19150324
http://www.bbc.com/news/health-19520629
http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/
http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004
http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria
http://www.medicalnewstoday.com/articles/256416.php
http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html
http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/
https://wn.com/Cockroaches,_Alligators_Other_Weird_Sources_Of_New_Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of smart, sneaky, and rapidly-evolving bacteria. To find new drugs to combat these superbugs, scientists are looking in some weird new places, like cockroaches’ brains, the blood of alligators, and more.
----------
Like SciShow? Want to help support us, and also get things to put on your walls, cover your torso and hold your liquids? Check out our awesome products over at DFTBA Records: http://dftba.com/scishow
Or help support us by subscribing to our page on Subbable: https://subbable.com/scishow
----------
Looking for SciShow elsewhere on the internet?
Facebook: http://www.facebook.com/scishow
Twitter: http://www.twitter.com/scishow
Tumblr: http://scishow.tumblr.com
Thanks Tank Tumblr: http://thankstank.tumblr.com
Sources:
http://science.howstuffworks.com/life/cellular-microscopic/10-weirdest-sources-antibiotics.htm
http://news.stanford.edu/pr/01/khosla37.html
http://www.sciencedaily.com/releases/2014/07/140710141351.htm
http://biomimicryinstitute.org/case-studies/case-studies/red-seaweed-inspired-antibiotics.html
http://www.the-scientist.com/?articles.view/articleNo/33818/title/Is-Frog-Skin-a-Red-Herring-/
http://news.nationalgeographic.com/news/2010/09/100909-cockroach-brains-mrsa-ecoli-antibiotics-science-health/
http://www.utne.com/science-and-technology/the-healing-power-of-cockroaches.aspx
http://www.popsci.com/science/article/2010-09/cockroaches-could-hold-key-next-gen-antibiotics-destroy-drug-resistant-infections
http://www.voanews.com/content/germ-ridden-roaches-could-lead-to-new-antibiotics/1579985.html
http://www.sciencedaily.com/releases/2010/09/100906202901.htm
http://www.wired.com/2010/09/cockroach-brains/
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4001588/
http://news.nationalgeographic.com/news/2008/04/080407-alligator-blood.html
http://www.medicalnewstoday.com/articles/103400.php
http://www.nature.com/nri/journal/v8/n5/full/nri2333.html
http://www.sciencedaily.com/releases/2008/04/080407074556.htm
http://www.neatorama.com/2013/02/16/Alligator-Blood-May-Lead-to-Powerful-New-Antibiotics/
http://myfwc.com/wildlifehabitats/managed/alligator/facts/
http://myuhcare.uhhospitals.org/health-and-wellness/health-articles/2014-08-14-powerful-new-antibiotics-from-alligator-blood.html
http://www.sun-sentinel.com/local/broward/sfl-cgatorscience14xaug14-story.html#page=1
http://mcdermott.opt.uh.edu/research2.html
http://www.sciencedaily.com/releases/2012/04/120411205423.htm
http://www.bbc.com/news/uk-scotland-scotland-business-19150324
http://www.bbc.com/news/health-19520629
http://www.the-scientist.com/?articles.view/articleNo/33642/title/Old-Ocean-Mold/
http://www.nature.com/news/ancient-fungi-found-in-deep-sea-mud-1.12004
http://www.researchgate.net/publication/259256720_Impact_of_antibiotic_residues_present_in_Baltic_Sea_sediments_on_the_growth_of_sedimentary_bacteria
http://www.medicalnewstoday.com/articles/256416.php
http://www.nature.com/ja/journal/v67/n10/full/ja201460a.html
http://scitechdaily.com/ancient-fungi-discovered-deep-in-ocean-floor-could-yield-new-antibiotics/
- published: 21 Nov 2014
- views: 851309
PILLS - Pharmaceutical Input and Elimination from Local Sources
- Order: Reorder
- Duration: 4:48
- Updated: 02 Jul 2012
- views: 429
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle a...
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals.
Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
https://wn.com/Pills_Pharmaceutical_Input_And_Elimination_From_Local_Sources
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in surface and drinking water, due to emissions from urban water cycle and poor degradation in conventional wastewater treatment, the INTERREG IVB-funded project PILLS investigated the feasibility, efficiency and sustainability of advanced decentralised treatment at hospitals.
Treatment facilities were installed in Germany, the Netherlands and Luxembourg (CHEM - Centre Hospitalier Emile Mayrisch) and a multi-criteria assessment of various technologies (environmental impacts, costs) was performed.
- published: 02 Jul 2012
- views: 429
PILLS Pharmaceutical input and Elimination from local sources.mp4
- Order: Reorder
- Duration: 3:27
- Updated: 22 Jun 2012
- views: 130
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst...
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
https://wn.com/Pills_Pharmaceutical_Input_And_Elimination_From_Local_Sources.Mp4
Even modern wastewater treatment plants in line with the current state of technology are unable to eliminate all substances from the water. This applies amongst others to drug residues. The PILLS project examines which wastewater treatment methods are best suited to eliminate pharmaceutical micropollutants and therefore amongst other things to counteract a further higher resistance to antibiotics.
- published: 22 Jun 2012
- views: 130
Pharmaceutical Impurities II
- Order: Reorder
- Duration: 13:48
- Updated: 22 Jul 2016
- views: 1232
Sources of impurity
Sources of impurity
https://wn.com/Pharmaceutical_Impurities_Ii
Sources of impurity
- published: 22 Jul 2016
- views: 1232
Sources of Pharmaceutical Grade Racetams
- Order: Reorder
- Duration: 9:48
- Updated: 17 Oct 2014
- views: 1125
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd pa...
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis.
Peak Nootropics
http://peaknootropics.com/?affiliates=63
New Star Nootropics
https://newstarnootropics.com/
PowderCity.com
http://powdercity.refr.cc/X2RV8NS
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
https://wn.com/Sources_Of_Pharmaceutical_Grade_Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics For Pharmaceutical Grade sources of Nootropics and corresponding 3rd party Certificates of Analysis.
Peak Nootropics
http://peaknootropics.com/?affiliates=63
New Star Nootropics
https://newstarnootropics.com/
PowderCity.com
http://powdercity.refr.cc/X2RV8NS
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 17 Oct 2014
- views: 1125
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Order: Reorder
- Duration: 27:20
- Updated: 24 Mar 2016
- views: 72
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free m...
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
https://wn.com/Why_Choose_Pharmaceutical_Grade_Nootropics_3Rd_Party_Verified_Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 24 Mar 2016
- views: 72
The Globalization of Pharmaceutical Industries
- Order: Reorder
- Duration: 8:18
- Updated: 30 Apr 2017
- views: 98
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-ko...
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217
http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut
https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/
https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf
http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten
http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html
https://www.youtube.com/watch?v=P3gBV6HjBRU
http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf
http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672
hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch
http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html
http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE
https://wn.com/The_Globalization_Of_Pharmaceutical_Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to.
sources:
http://www.tagesanzeiger.ch/wirtschaft/unternehmen-und-konjunktur/Der-Kampf-um-guenstige-Medikamente/story/28624217
http://www.arte.tv/guide/de/067129-000-A/das-geschaft-mit-dem-blut
https://www.publiceye.ch/de/themen-hintergruende/gesundheit/patente-und-zugang-zu-medikamenten/zugang-zu-impfstoffen/
https://dornsife.usc.edu/assets/sites/486/docs/Pouw_Welch_Essay.pdf
http://www.srf.ch/wissen/mensch/was-tut-big-pharma-fuer-die-aermsten-patienten
http://www.spiegel.de/wissenschaft/mensch/medikamententests-afrikanisches-roulette-a-577109.html
https://www.youtube.com/watch?v=P3gBV6HjBRU
http://www.szucs.ch/cgi-bin/dms/files/27.1%20vorlesungsunterlagen%20medikamentenentwicklung.pdf
http://www.deutschlandradiokultur.de/medikamententests-versuchslabor-afrika.976.de.html?dram:article_id=334672
hte-zeitung.de/index.php?id=3843tp://www.pharmazeutisch
http://www.spiegel.de/wissenschaft/medizin/klinische-studien-in-indien-pharmakonzerne-sparen-entwicklungskosten-a-829818.html
http://ir3.quartalflife.com/data/celesio/businessreport/celesio_2011/index.php?content=25&culture=de-DE
- published: 30 Apr 2017
- views: 98
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
- Order: Reorder
- Duration: 2:36
- Updated: 19 Jun 2015
- views: 3829
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Auto...
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute.
Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation.
The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute.
Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com.
https://wn.com/Pharmaceutical_Cartoning_System_With_Robotic_Pick_Place_Trans_Automation_Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceutical-robots.aspx
FANUC America Authorized System Integrator Trans Automation Technologies was tasked to develop an automatic cartoning system for small pharmaceutical bottles. The system would reform a process that was erratic and inconsistent with an automated process that could provide reliability and consistent rates of packaging over 90 bottles per minute.
Trans Automation Technologies was able to provide an automated system to meet their customer’s needs. This reliable system starts as the small pharmaceutical bottles enter on a pre-feeder conveyor with a bulk hopper. A vibratory bowl feeder feeds the individual bottles upright into custom conveyors with line controls. A dual-sided auto-labeler applies labels to the bottles. Then, a camera with dual-sided vision inspects both sides of the bottles to verify tamper band presence and proper label orientation.
The bottles continue down the line to a gripper belt “bottomless” conveyor. The bottles are picked and placed into their packaging by FANUC’s high-speed M-1iA/0.5S four-axis delta-style robot. In addition to it’s unique speed and efficiency, the FANCU M-1iA robot’s compact size is a benefit to this system, minimizing its overall footprint. The FANUC M-1iA delta robot consistently provides packaging speeds of more than 90 bottles per minute.
Finally, a camera system verifies that cartons are full prior to closure, and the horizontal carton erector closes the cartons. To learn more about FANUC America Authorized System Integrator Trans Automation Technologies, please visit http://www.transautotech.com.
- published: 19 Jun 2015
- views: 3829
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
- Order: Reorder
- Duration: 5:53
- Updated: 26 Sep 2016
- views: 17203
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insigh...
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016.
Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/
https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
https://wn.com/These_13_Corporations_Are_Big_Pharma_Their_History,_Crimes,_And_Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of Wisdom: http://www.eraofwisdom.org/our-era/
This video provides insight into who exactly "big pharma" is. This is a preview to the Era of Wisdom documentary "Toddlers on Adderall: History of "Big Pharma" and the Major Players," to be released December 28, 2016.
Transcript & Sources: http://www.eraofwisdom.org/13-corporations-big-pharma-history-crimes-products/
https://docs.google.com/document/d/1ZH5iiP9mv1Snzv-fkrcUn_2G-xanYoWhpa0H-u8U1NQ/edit
- published: 26 Sep 2016
- views: 17203
-
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks. Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics on Facebook https://www.facebook.com/limitlessmindset on Twitter http://twitter.com/#!/jroseland on Google+ https://plus.google.com/+JonathanRoseland
published: 24 Mar 2016 -
Uppers and Downers: Where is the Pharmaceutical Industry Headed?
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry sources. But drug companies put much of their attention on developing and marketing proven "me-too" drugs — statins, ace inhibitors, SSRIs — not therapies for rare and neglected diseases or the cheaper diagnostics that are urgently needed in developing countries. Blockbuster drugs are still hugely important to their bottom line, but financial incentives may be shifting to patient outcomes, not per-pill sales. How is the pipeline for drug and device development changing? Do we need to redesign clinical trials? Where are the breakthrough therapies? Featuring: Margaret A. Hamburg Andrew Jack, Moderator Freda Lewis-Hall Neeraj Mistry Krishna Yeshwant The Aspen Ideas Festival is the nation's premier, pub...
published: 26 Jun 2014 -
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral Anti-Diabetic Drugs-The New Antidiabetic Agents]
published: 13 Mar 2016 -
MARCH 1 2017 OWC pharmaceutical CEO says at WALL St Conference cream in 30 days green light to sell
OWC is a pharmaceutical company that has 8 patterns for MMJ products first product is our patented Psoriasis Cream the CEO says we should be in full roll out within 30 days Worldwide and the only other medical cannabis pharmaceutical Company is GWPH pharmaceutical company that trades at $130.00 a share OWC pharmaceutical stock is so Undervalued right now and trades at $ 2.00 a share but after the Wall Street hedge funds start buying the pps could go to the $ 15 to 20 dollar range BEFORE OWC PHARMACEUTICAL start selling the psoriasis cream globally we will be a minimum 50.00 stock the company plans to move to the NASDAQ listen to the recording of the CEO talk about OWC pharmaceutical how excited he is that after 3 years of testing the cream it's ready to go also the sublingual patente...
published: 02 Mar 2017 -
The Truth About Cancer: A Global Quest - Episode 1
Welcome to Episode 1 of "The Truth About Cancer: A Global Quest". This Episode is about the true history of Chemotherapy and the pharmaceutical monopoly. We welcome you to watch this Episode completely free. If you would like to support our mission and own all Episodes of this eye-opening Docu-Series, please follow this link: https://go2.thetruthaboutcancer.com/agq-encore/silver/ Follow us on Facebook: https://www.facebook.com/thetruthaboutcancer Follow us on Pinterest: https://www.pinterest.com/truthboutcancer Our mission is to educate the world, expose lies & empower people with life-saving knowledge. Help us and share the truth!
published: 16 Oct 2015 -
Good Pharma: Better for business, better for patients - DigiPharm 2013
David Hunt, Chief Executive, HAVAS LYNX presents Good Pharma: Better for patients, better for business at DigiPharm 2013. Pharma finds itself on the cusp of a tremendous opportunity. Patients and professionals are increasingly seeking reliable sources of tools, services and information to enhance and ease their experiences. Healthcare providers are in desperate need of expertise to assist in streamlining services and improving patient care. Additionally, there is an ever-increasing artillery of emerging technologies that, harnessed correctly, will have incredibly meaningful benefits in the field of medicine. These three forces are all vying for change in healthcare and all three need pharma to orchestrate a scenario where this is possible. But, all three demand that pharma demonstrates th...
published: 04 Nov 2013 -
A medicine cabinet in your garden?
Professor Monique Simmonds, Director of the Kew Innovation Unit, Deputy Keeper & Head of Sustainable Uses of Plants Group, gave a talk on the research into the economic uses of plants and fungi, their potential as cosmetics, pharmaceutical and agrochemical leads, and as sources of sustainably harvested medicines. This lecture was kindly sponsored by GSK. http://bit.ly/LLiEIe See more events from the Chemistry Centre, London
published: 10 Aug 2012 -
Cleanroom HVAC Design Webinar
Mr. Wei Sun, president of Engsysco, covers a variety of topics in the Cleanroom HVAC Design Webinar. Learning points include Standards and Classifications, Particle/Contamination Sources and Control, Design Considerations, Flow Patterns and Floor Arrangements, Airflow Quantity and Demand Flow Control, Pressurization and Airlocks, in addition to Typical HVAC Air-Handling Systems and Selection.
published: 25 Aug 2015 -
Pharmaceutical Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs. Sources: http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
published: 26 Nov 2014 -
Webinar: Maximising impact for pharmaceutical applications
Webinar slides: http://www.slideshare.net/open_phacts/open-phacts-webinar-june-2016-data2discovery The fourth in our monthly webinar series, covering the latest updates to the Open PHACTS Discovery Platform, and how they can benefit you and your research. Data2Discovery, Inc. is creating systems that map proprietary and other data sources into semantic linked form that can be combined with Open PHACTS data in a smart data lake. This month David Wild demonstrates Data2Discovery's developments, with an application they have developed for Phenotypic Screening analysis called P3.
published: 29 Jun 2016
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Order: Reorder
- Duration: 27:20
- Updated: 24 Mar 2016
- views: 72
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free m...
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
https://wn.com/Why_Choose_Pharmaceutical_Grade_Nootropics_3Rd_Party_Verified_Sources
Let me confirm something you already know on a gut level; the supplement industry is a capitalist's wild wild west, a profiteers paradise, an unregulated free market, and consumers should beware. I've been a pretty hard core consumer of Nootropics for going on 4 years now and I'm increasingly becoming less and less of a believer in the majority of Stacks.
Full Article http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics
on Facebook
https://www.facebook.com/limitlessmindset
on Twitter
http://twitter.com/#!/jroseland
on Google+
https://plus.google.com/+JonathanRoseland
- published: 24 Mar 2016
- views: 72
Uppers and Downers: Where is the Pharmaceutical Industry Headed?
- Order: Reorder
- Duration: 1:02:16
- Updated: 26 Jun 2014
- views: 1622
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry sources. But drug companies put much of their attention on developing ...
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry sources. But drug companies put much of their attention on developing and marketing proven "me-too" drugs — statins, ace inhibitors, SSRIs — not therapies for rare and neglected diseases or the cheaper diagnostics that are urgently needed in developing countries. Blockbuster drugs are still hugely important to their bottom line, but financial incentives may be shifting to patient outcomes, not per-pill sales. How is the pipeline for drug and device development changing? Do we need to redesign clinical trials? Where are the breakthrough therapies?
Featuring:
Margaret A. Hamburg
Andrew Jack, Moderator
Freda Lewis-Hall
Neeraj Mistry
Krishna Yeshwant
The Aspen Ideas Festival is the nation's premier, public gathering place for leaders from around the globe and across many disciplines to engage in deep and inquisitive discussion of the ideas and issues that both shape our lives and challenge our times. Learn more at: http://www.aspenideas.org/
Follow us on:
Facebook https://www.facebook.com/aspenideas
Twitter https://twitter.com/aspenideas
LinkedIn https://www.linkedin.com/channels/aspenideas
You can also follow the Aspen Institute:
Instagram http://instagram.com/aspeninstitute
Facebook https://www.facebook.com/AspenInstitute
Twitter https://twitter.com/aspeninstitute
LinkedIn https://www.linkedin.com/company/the-aspen-institute
Pinterest http://www.pinterest.com/aspeninstitute
Get regular updates from the Ideas Festival: http://www.aspenideas.org/subscribe-newsletter
https://wn.com/Uppers_And_Downers_Where_Is_The_Pharmaceutical_Industry_Headed
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry sources. But drug companies put much of their attention on developing and marketing proven "me-too" drugs — statins, ace inhibitors, SSRIs — not therapies for rare and neglected diseases or the cheaper diagnostics that are urgently needed in developing countries. Blockbuster drugs are still hugely important to their bottom line, but financial incentives may be shifting to patient outcomes, not per-pill sales. How is the pipeline for drug and device development changing? Do we need to redesign clinical trials? Where are the breakthrough therapies?
Featuring:
Margaret A. Hamburg
Andrew Jack, Moderator
Freda Lewis-Hall
Neeraj Mistry
Krishna Yeshwant
The Aspen Ideas Festival is the nation's premier, public gathering place for leaders from around the globe and across many disciplines to engage in deep and inquisitive discussion of the ideas and issues that both shape our lives and challenge our times. Learn more at: http://www.aspenideas.org/
Follow us on:
Facebook https://www.facebook.com/aspenideas
Twitter https://twitter.com/aspenideas
LinkedIn https://www.linkedin.com/channels/aspenideas
You can also follow the Aspen Institute:
Instagram http://instagram.com/aspeninstitute
Facebook https://www.facebook.com/AspenInstitute
Twitter https://twitter.com/aspeninstitute
LinkedIn https://www.linkedin.com/company/the-aspen-institute
Pinterest http://www.pinterest.com/aspeninstitute
Get regular updates from the Ideas Festival: http://www.aspenideas.org/subscribe-newsletter
- published: 26 Jun 2014
- views: 1622
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral Anti-Diabetic Drugs-The New Antidiabetic Agents]
- Order: Reorder
- Duration: 1:47:50
- Updated: 13 Mar 2016
- views: 4438
- published: 13 Mar 2016
- views: 4438
MARCH 1 2017 OWC pharmaceutical CEO says at WALL St Conference cream in 30 days green light to sell
- Order: Reorder
- Duration: 38:39
- Updated: 02 Mar 2017
- views: 1790
OWC is a pharmaceutical company that has 8 patterns for MMJ products first product is our patented Psoriasis Cream the CEO says we should be in full roll out w...
OWC is a pharmaceutical company that has 8 patterns for MMJ products first product is our patented Psoriasis Cream the CEO says we should be in full roll out within 30 days Worldwide and the only other medical cannabis pharmaceutical Company is GWPH pharmaceutical company that trades at $130.00 a share OWC pharmaceutical stock is so Undervalued right now and trades at $ 2.00 a share but after the Wall Street hedge funds start buying the pps could go to the $ 15 to 20 dollar range BEFORE OWC PHARMACEUTICAL start selling the psoriasis cream globally we will be a minimum 50.00 stock the company plans to move to the NASDAQ listen to the recording of the CEO talk about OWC pharmaceutical how excited he is that after 3 years of testing the cream it's ready to go also the sublingual patented tablets will also be green lighted to start selling this year OWC is also going to be in the Frist MMJ ETF there is just so much positive things coming out this year for OWC fact the medical marijuana pharmaceutical industry is worth 20 billion dollars right now by the year 2020 it will be a 50 billion dollar industry ticker OWCP STRONG BUY
https://wn.com/March_1_2017_Owc_Pharmaceutical_Ceo_Says_At_Wall_St_Conference_Cream_In_30_Days_Green_Light_To_Sell
OWC is a pharmaceutical company that has 8 patterns for MMJ products first product is our patented Psoriasis Cream the CEO says we should be in full roll out within 30 days Worldwide and the only other medical cannabis pharmaceutical Company is GWPH pharmaceutical company that trades at $130.00 a share OWC pharmaceutical stock is so Undervalued right now and trades at $ 2.00 a share but after the Wall Street hedge funds start buying the pps could go to the $ 15 to 20 dollar range BEFORE OWC PHARMACEUTICAL start selling the psoriasis cream globally we will be a minimum 50.00 stock the company plans to move to the NASDAQ listen to the recording of the CEO talk about OWC pharmaceutical how excited he is that after 3 years of testing the cream it's ready to go also the sublingual patented tablets will also be green lighted to start selling this year OWC is also going to be in the Frist MMJ ETF there is just so much positive things coming out this year for OWC fact the medical marijuana pharmaceutical industry is worth 20 billion dollars right now by the year 2020 it will be a 50 billion dollar industry ticker OWCP STRONG BUY
- published: 02 Mar 2017
- views: 1790
The Truth About Cancer: A Global Quest - Episode 1
- Order: Reorder
- Duration: 1:58:50
- Updated: 16 Oct 2015
- views: 3090132
Welcome to Episode 1 of "The Truth About Cancer: A Global Quest".
This Episode is about the true history of Chemotherapy and the pharmaceutical monopoly. We we...
Welcome to Episode 1 of "The Truth About Cancer: A Global Quest".
This Episode is about the true history of Chemotherapy and the pharmaceutical monopoly. We welcome you to watch this Episode completely free.
If you would like to support our mission and own all Episodes of this eye-opening Docu-Series, please follow this link:
https://go2.thetruthaboutcancer.com/agq-encore/silver/
Follow us on Facebook: https://www.facebook.com/thetruthaboutcancer
Follow us on Pinterest:
https://www.pinterest.com/truthboutcancer
Our mission is to educate the world, expose lies & empower people with life-saving knowledge. Help us and share the truth!
https://wn.com/The_Truth_About_Cancer_A_Global_Quest_Episode_1
Welcome to Episode 1 of "The Truth About Cancer: A Global Quest".
This Episode is about the true history of Chemotherapy and the pharmaceutical monopoly. We welcome you to watch this Episode completely free.
If you would like to support our mission and own all Episodes of this eye-opening Docu-Series, please follow this link:
https://go2.thetruthaboutcancer.com/agq-encore/silver/
Follow us on Facebook: https://www.facebook.com/thetruthaboutcancer
Follow us on Pinterest:
https://www.pinterest.com/truthboutcancer
Our mission is to educate the world, expose lies & empower people with life-saving knowledge. Help us and share the truth!
- published: 16 Oct 2015
- views: 3090132
Good Pharma: Better for business, better for patients - DigiPharm 2013
- Order: Reorder
- Duration: 25:00
- Updated: 04 Nov 2013
- views: 15098
David Hunt, Chief Executive, HAVAS LYNX presents Good Pharma: Better for patients, better for business at DigiPharm 2013.
Pharma finds itself on the cusp of a ...
David Hunt, Chief Executive, HAVAS LYNX presents Good Pharma: Better for patients, better for business at DigiPharm 2013.
Pharma finds itself on the cusp of a tremendous opportunity. Patients and professionals are increasingly seeking reliable sources of tools, services and information to enhance and ease their experiences. Healthcare providers are in desperate need of expertise to assist in streamlining services and improving patient care. Additionally, there is an ever-increasing artillery of emerging technologies that, harnessed correctly, will have incredibly meaningful benefits in the field of medicine. These three forces are all vying for change in healthcare and all three need pharma to orchestrate a scenario where this is possible. But, all three demand that pharma demonstrates that it has their interests at heart, that it is ethical, that it is responsible; that it is good.
Download the supporting white paper here:
http://www.havaslynx.com/wp-content/uploads/2013/10/07.GOOD_PHARMA_2013_103.pdf
https://wn.com/Good_Pharma_Better_For_Business,_Better_For_Patients_Digipharm_2013
David Hunt, Chief Executive, HAVAS LYNX presents Good Pharma: Better for patients, better for business at DigiPharm 2013.
Pharma finds itself on the cusp of a tremendous opportunity. Patients and professionals are increasingly seeking reliable sources of tools, services and information to enhance and ease their experiences. Healthcare providers are in desperate need of expertise to assist in streamlining services and improving patient care. Additionally, there is an ever-increasing artillery of emerging technologies that, harnessed correctly, will have incredibly meaningful benefits in the field of medicine. These three forces are all vying for change in healthcare and all three need pharma to orchestrate a scenario where this is possible. But, all three demand that pharma demonstrates that it has their interests at heart, that it is ethical, that it is responsible; that it is good.
Download the supporting white paper here:
http://www.havaslynx.com/wp-content/uploads/2013/10/07.GOOD_PHARMA_2013_103.pdf
- published: 04 Nov 2013
- views: 15098
A medicine cabinet in your garden?
- Order: Reorder
- Duration: 1:23:28
- Updated: 10 Aug 2012
- views: 645
Professor Monique Simmonds, Director of the Kew Innovation Unit, Deputy Keeper & Head of Sustainable Uses of Plants Group, gave a talk on the research into the ...
Professor Monique Simmonds, Director of the Kew Innovation Unit, Deputy Keeper & Head of Sustainable Uses of Plants Group, gave a talk on the research into the economic uses of plants and fungi, their potential as cosmetics, pharmaceutical and agrochemical leads, and as sources of sustainably harvested medicines.
This lecture was kindly sponsored by GSK.
http://bit.ly/LLiEIe See more events from the Chemistry Centre, London
https://wn.com/A_Medicine_Cabinet_In_Your_Garden
Professor Monique Simmonds, Director of the Kew Innovation Unit, Deputy Keeper & Head of Sustainable Uses of Plants Group, gave a talk on the research into the economic uses of plants and fungi, their potential as cosmetics, pharmaceutical and agrochemical leads, and as sources of sustainably harvested medicines.
This lecture was kindly sponsored by GSK.
http://bit.ly/LLiEIe See more events from the Chemistry Centre, London
- published: 10 Aug 2012
- views: 645
Cleanroom HVAC Design Webinar
- Order: Reorder
- Duration: 41:34
- Updated: 25 Aug 2015
- views: 11649
Mr. Wei Sun, president of Engsysco, covers a variety of topics in the Cleanroom HVAC Design Webinar. Learning points include Standards and Classifications, Part...
Mr. Wei Sun, president of Engsysco, covers a variety of topics in the Cleanroom HVAC Design Webinar. Learning points include Standards and Classifications, Particle/Contamination Sources and Control, Design Considerations, Flow Patterns and Floor Arrangements, Airflow Quantity and Demand Flow Control, Pressurization and Airlocks, in addition to Typical HVAC Air-Handling Systems and Selection.
https://wn.com/Cleanroom_Hvac_Design_Webinar
Mr. Wei Sun, president of Engsysco, covers a variety of topics in the Cleanroom HVAC Design Webinar. Learning points include Standards and Classifications, Particle/Contamination Sources and Control, Design Considerations, Flow Patterns and Floor Arrangements, Airflow Quantity and Demand Flow Control, Pressurization and Airlocks, in addition to Typical HVAC Air-Handling Systems and Selection.
- published: 25 Aug 2015
- views: 11649
Pharmaceutical Prison
- Order: Reorder
- Duration: 25:12
- Updated: 26 Nov 2014
- views: 544
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural r...
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs.
Sources:
http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
https://wn.com/Pharmaceutical_Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry otherwise known as "Big Pharma" and how they continually condemn natural remedies in order to keep the general public sick so they can profit off of the general public especially the hypochondriacs.
Sources:
http://starshipearththebigpicture.com/2014/01/21/why-those-promised-cures-for-diseases-will-never-come-from-pharmaceutical-research/
- published: 26 Nov 2014
- views: 544
Webinar: Maximising impact for pharmaceutical applications
- Order: Reorder
- Duration: 47:17
- Updated: 29 Jun 2016
- views: 58
Webinar slides: http://www.slideshare.net/open_phacts/open-phacts-webinar-june-2016-data2discovery
The fourth in our monthly webinar series, covering the lates...
Webinar slides: http://www.slideshare.net/open_phacts/open-phacts-webinar-june-2016-data2discovery
The fourth in our monthly webinar series, covering the latest updates to the Open PHACTS Discovery Platform, and how they can benefit you and your research.
Data2Discovery, Inc. is creating systems that map proprietary and other data sources into semantic linked form that can be combined with Open PHACTS data in a smart data lake. This month David Wild demonstrates Data2Discovery's developments, with an application they have developed for Phenotypic Screening analysis called P3.
https://wn.com/Webinar_Maximising_Impact_For_Pharmaceutical_Applications
Webinar slides: http://www.slideshare.net/open_phacts/open-phacts-webinar-june-2016-data2discovery
The fourth in our monthly webinar series, covering the latest updates to the Open PHACTS Discovery Platform, and how they can benefit you and your research.
Data2Discovery, Inc. is creating systems that map proprietary and other data sources into semantic linked form that can be combined with Open PHACTS data in a smart data lake. This month David Wild demonstrates Data2Discovery's developments, with an application they have developed for Phenotypic Screening analysis called P3.
- published: 29 Jun 2016
- views: 58
- Playlist
- Chat
9:47
Pharmaceutical Impurities I
Introduction, classification and sources of impurities
published: 22 Jul 2016
Pharmaceutical Impurities I
Pharmaceutical Impurities I
- Report rights infringement
- published: 22 Jul 2016
- views: 1331
8:33
Cockroaches, Alligators & Other Weird Sources of New Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of sm...
published: 21 Nov 2014
Cockroaches, Alligators & Other Weird Sources of New Drugs
Cockroaches, Alligators & Other Weird Sources of New Drugs
- Report rights infringement
- published: 21 Nov 2014
- views: 851309
4:48
PILLS - Pharmaceutical Input and Elimination from Local Sources
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in...
published: 02 Jul 2012
PILLS - Pharmaceutical Input and Elimination from Local Sources
PILLS - Pharmaceutical Input and Elimination from Local Sources
- Report rights infringement
- published: 02 Jul 2012
- views: 429
3:27
PILLS Pharmaceutical input and Elimination from local sources.mp4
Even modern wastewater treatment plants in line with the current state of technology are u...
published: 22 Jun 2012
PILLS Pharmaceutical input and Elimination from local sources.mp4
PILLS Pharmaceutical input and Elimination from local sources.mp4
- Report rights infringement
- published: 22 Jun 2012
- views: 130
13:48
Pharmaceutical Impurities II
Sources of impurity
published: 22 Jul 2016
Pharmaceutical Impurities II
Pharmaceutical Impurities II
- Report rights infringement
- published: 22 Jul 2016
- views: 1232
9:48
Sources of Pharmaceutical Grade Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics F...
published: 17 Oct 2014
Sources of Pharmaceutical Grade Racetams
Sources of Pharmaceutical Grade Racetams
- Report rights infringement
- published: 17 Oct 2014
- views: 1125
27:20
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a cap...
published: 24 Mar 2016
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Report rights infringement
- published: 24 Mar 2016
- views: 72
8:18
The Globalization of Pharmaceutical Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to....
published: 30 Apr 2017
The Globalization of Pharmaceutical Industries
The Globalization of Pharmaceutical Industries
- Report rights infringement
- published: 30 Apr 2017
- views: 98
2:36
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceuti...
published: 19 Jun 2015
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
- Report rights infringement
- published: 19 Jun 2015
- views: 3829
5:53
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of W...
published: 26 Sep 2016
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
- Report rights infringement
- published: 26 Sep 2016
- views: 17203
2:01
Kissei Pharmaceutical
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you c...
published: 02 Nov 2015
Kissei Pharmaceutical
Kissei Pharmaceutical
- Report rights infringement
- published: 02 Nov 2015
- views: 41
2:01
Ultragenyx Pharmaceutical
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you...
published: 26 Nov 2016
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
- Report rights infringement
- published: 26 Nov 2016
- views: 83
0:36
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
In particular the research and analysis discuss revenue prospects, including forecasts to ...
published: 29 Apr 2016
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations CMOs 2015-2025
- Report rights infringement
- published: 29 Apr 2016
- views: 86
1:11:17
Pharmaceutical statistics - data sharing
Data Sharing: one pharmaceutical company's approach and the statistical challenges envisag...
published: 07 Mar 2016
Pharmaceutical statistics - data sharing
Pharmaceutical statistics - data sharing
- Report rights infringement
- published: 07 Mar 2016
- views: 393
25:12
Pharmaceutical Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry othe...
published: 26 Nov 2014
Pharmaceutical Prison
Pharmaceutical Prison
- Report rights infringement
- published: 26 Nov 2014
- views: 544
12:07
Consumerism of the Pharmaceutical Industry
Our teacher asked us to discuss a facet of consumerism. I chose the Pharmaceutical Indust...
published: 30 Nov 2010
Consumerism of the Pharmaceutical Industry
Consumerism of the Pharmaceutical Industry
- Report rights infringement
- published: 30 Nov 2010
- views: 39
- Playlist
- Chat
9:47
Pharmaceutical Impurities I
Introduction, classification and sources of impurities
published: 22 Jul 2016
Pharmaceutical Impurities I
Pharmaceutical Impurities I
- Report rights infringement
- published: 22 Jul 2016
- views: 1331
8:33
Cockroaches, Alligators & Other Weird Sources of New Drugs
Some of humanity’s favorite antibiotics are starting to lose their mojo, in the face of sm...
published: 21 Nov 2014
Cockroaches, Alligators & Other Weird Sources of New Drugs
Cockroaches, Alligators & Other Weird Sources of New Drugs
- Report rights infringement
- published: 21 Nov 2014
- views: 851309
4:48
PILLS - Pharmaceutical Input and Elimination from Local Sources
http://www.pills-project.eu
Responding to growing concern about pharmaceutical residues in...
published: 02 Jul 2012
PILLS - Pharmaceutical Input and Elimination from Local Sources
PILLS - Pharmaceutical Input and Elimination from Local Sources
- Report rights infringement
- published: 02 Jul 2012
- views: 429
3:27
PILLS Pharmaceutical input and Elimination from local sources.mp4
Even modern wastewater treatment plants in line with the current state of technology are u...
published: 22 Jun 2012
PILLS Pharmaceutical input and Elimination from local sources.mp4
PILLS Pharmaceutical input and Elimination from local sources.mp4
- Report rights infringement
- published: 22 Jun 2012
- views: 130
13:48
Pharmaceutical Impurities II
Sources of impurity
published: 22 Jul 2016
Pharmaceutical Impurities II
Pharmaceutical Impurities II
- Report rights infringement
- published: 22 Jul 2016
- views: 1232
9:48
Sources of Pharmaceutical Grade Racetams
http://www.limitlessmindset.com/mind-power-products/1008-pharmaceutical-grade-nootropics F...
published: 17 Oct 2014
Sources of Pharmaceutical Grade Racetams
Sources of Pharmaceutical Grade Racetams
- Report rights infringement
- published: 17 Oct 2014
- views: 1125
27:20
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a cap...
published: 24 Mar 2016
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Report rights infringement
- published: 24 Mar 2016
- views: 72
8:18
The Globalization of Pharmaceutical Industries
A brief explanation of what the globalization of the pharmaceutical industry can lead to....
published: 30 Apr 2017
The Globalization of Pharmaceutical Industries
The Globalization of Pharmaceutical Industries
- Report rights infringement
- published: 30 Apr 2017
- views: 98
2:36
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical bottle packaging: http://robot.fanucamerica.com/Products/Robots/pharmaceuti...
published: 19 Jun 2015
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
Pharmaceutical Cartoning System with Robotic Pick & Place - Trans Automation Technologies
- Report rights infringement
- published: 19 Jun 2015
- views: 3829
5:53
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
Full documentary: https://www.youtube.com/watch?v=5rZn1xccrig
Donate to support Era of W...
published: 26 Sep 2016
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
These 13 Corporations Are "Big Pharma": Their History, Crimes, and Products
- Report rights infringement
- published: 26 Sep 2016
- views: 17203
- Playlist
- Chat
27:20
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Let me confirm something you already know on a gut level; the supplement industry is a cap...
published: 24 Mar 2016
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
Why Choose Pharmaceutical Grade Nootropics+3rd Party Verified Sources
- Report rights infringement
- published: 24 Mar 2016
- views: 72
1:02:16
Uppers and Downers: Where is the Pharmaceutical Industry Headed?
The global pharmaceutical market could reach $1.2 trillion by 2016, according to industry ...
published: 26 Jun 2014
Uppers and Downers: Where is the Pharmaceutical Industry Headed?
Uppers and Downers: Where is the Pharmaceutical Industry Headed?
- Report rights infringement
- published: 26 Jun 2014
- views: 1622
1:47:50
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral Anti-Diabetic Drugs-The New Antidiabetic Agents]
published: 13 Mar 2016
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral Anti-Diabetic Drugs-The New Antidiabetic Agents]
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral Anti-Diabetic Drugs-The New Antidiabetic Agents]
- Report rights infringement
- published: 13 Mar 2016
- views: 4438
38:39
MARCH 1 2017 OWC pharmaceutical CEO says at WALL St Conference cream in 30 days green light to sell
OWC is a pharmaceutical company that has 8 patterns for MMJ products first product is our ...
published: 02 Mar 2017
MARCH 1 2017 OWC pharmaceutical CEO says at WALL St Conference cream in 30 days green light to sell
MARCH 1 2017 OWC pharmaceutical CEO says at WALL St Conference cream in 30 days green light to sell
- Report rights infringement
- published: 02 Mar 2017
- views: 1790
1:58:50
The Truth About Cancer: A Global Quest - Episode 1
Welcome to Episode 1 of "The Truth About Cancer: A Global Quest".
This Episode is about t...
published: 16 Oct 2015
The Truth About Cancer: A Global Quest - Episode 1
The Truth About Cancer: A Global Quest - Episode 1
- Report rights infringement
- published: 16 Oct 2015
- views: 3090132
25:00
Good Pharma: Better for business, better for patients - DigiPharm 2013
David Hunt, Chief Executive, HAVAS LYNX presents Good Pharma: Better for patients, better ...
published: 04 Nov 2013
Good Pharma: Better for business, better for patients - DigiPharm 2013
Good Pharma: Better for business, better for patients - DigiPharm 2013
- Report rights infringement
- published: 04 Nov 2013
- views: 15098
1:23:28
A medicine cabinet in your garden?
Professor Monique Simmonds, Director of the Kew Innovation Unit, Deputy Keeper & Head of S...
published: 10 Aug 2012
A medicine cabinet in your garden?
A medicine cabinet in your garden?
- Report rights infringement
- published: 10 Aug 2012
- views: 645
41:34
Cleanroom HVAC Design Webinar
Mr. Wei Sun, president of Engsysco, covers a variety of topics in the Cleanroom HVAC Desig...
published: 25 Aug 2015
Cleanroom HVAC Design Webinar
Cleanroom HVAC Design Webinar
- Report rights infringement
- published: 25 Aug 2015
- views: 11649
25:12
Pharmaceutical Prison
This week I want to discuss the ongoing corruption within the pharmaceutical industry othe...
published: 26 Nov 2014
Pharmaceutical Prison
Pharmaceutical Prison
- Report rights infringement
- published: 26 Nov 2014
- views: 544
47:17
Webinar: Maximising impact for pharmaceutical applications
Webinar slides: http://www.slideshare.net/open_phacts/open-phacts-webinar-june-2016-data2d...
published: 29 Jun 2016
Webinar: Maximising impact for pharmaceutical applications
Webinar: Maximising impact for pharmaceutical applications
- Report rights infringement
- published: 29 Jun 2016
- views: 58
Why Choose Pharmaceutical Grade Nootropics+3rd Par...
Uppers and Downers: Where is the Pharmaceutical In...
51.Dr.Ahmed Abdelrahman [Sources of Insulin & Oral...
MARCH 1 2017 OWC pharmaceutical CEO says at WALL S...
The Truth About Cancer: A Global Quest - Episode 1...
Good Pharma: Better for business, better for patie...
A medicine cabinet in your garden?...
Cleanroom HVAC Design Webinar...
Pharmaceutical Prison...
Webinar: Maximising impact for pharmaceutical appl...
back
Study gives first proof that the Earth has a natural thermostat
Edit SpaceDaily 22 Aug 2017
Paris (SPX) Aug 21, 2017. New data provides the first proof that the Earth has a natural thermostat which enables the planet to recover from extremes of climate change - but the recovery timescales are significant. This work was presented at the Goldschmidt conference in Paris, and has just been published in the peer-reviewed journal Geochemical Perspectives Letters*. The idea of a natural temperature thermostat wa ... ....
back
North Korea warns ‘US will live in fear’
Edit Raw Story 22 Aug 2017
North Korea has warned Donald Trump that all it has to do is “put its hand on a button and press it when the right time comes” in a video released ahead of the U.S.’ military drill with South Korea. The propaganda video, released on Sunday evening, issued a stark threat to the U.S. president that... ....
back
If we enter India, it will be chaos: China
Edit Kashmir Observer 22 Aug 2017
Beijing—China on Tuesday said there will be "utter chaos" if its troops entered India on the pretext that Indian border infrastructure posed a threat to Beijing. The Chinese Foreign Ministry said India's logic that Chinese road building in Doklam on the border posed a threat to New Delhi was "ridiculous and vicious" ... "The Indian side illegally crossed the boundary on the excuse of ... ....
back
India's top court suspends controversial Muslim divorce law
Edit This is Money 22 Aug 2017
"This is a sensitive case where sentiments are involved. We are directing the Union of India to consider appropriate legislation in this regard," Justice J.S ... ....
Pharmaceutical Contract Packaging Market Surge Towards Solid Growth by 2024
Edit Community news 22 Aug 2017
Global Pharmaceutical Contract Packaging Market ... Outsourcing of the packaging activities to the third party manufacturers is pharmaceutical contract packaging ... In the coming times, this market will have tremendous demand owing to the increasing demand for the pharmaceutical drugs. Request Free Sample Report @ https.//www.zionmarketresearch.com/sample/pharmaceutical-contract-packaging-market ....
Blow Fill Seal Technology Market Worth US$ 7,208 Mn by 2027
Edit Community news 22 Aug 2017
This scenario has created a demand for pharmaceutical products that have accurately measured doses and provide ease of use and level of comfort to patients. Blow fill seal technology has been extensively employed by pharmaceutical companies in North America for the manufacturing of unit dose packaging solutions as a solution to improve patient adherence to prescribed drug regimes....
Growing Industrialization will influence the White Mineral Oil Market Growth
Edit Community news 22 Aug 2017
The inert nature of this white mineral oil makes it easy to use it as lubricate, smoothens, soften and resist moisture in many formulations making it very useful in the pharmaceutical and personal care preparations ... These wide applications of white mineral oil is creating a high demand pharmaceutical, industrial and food sectors and this demand is anticipated to grow during the forecast period....
Finalists Announced for 2017 LogiPharma Supply Chain Awards
Edit Market Watch 22 Aug 2017
Industry awards celebrating projects and teams that have transformed supply chains in pharmaceutical companies ... Teva Pharmaceutical Industries LTD ... Teva Pharmaceutical Industries Ltd. Bluefish Pharmaceuticals AB ... the world's leading pharmaceutical companies on Thursday 9thNovember 2017 at the Porsche Museum in Stuttgart, Germany ... SOURCE LogiPharma....
Mitochondrial Myopathies Treatment Market Size, Status and Forecast 2023
Edit Community news 22 Aug 2017
Market Research Future Publish a New Report on - “Mitochondrial Myopathies Market Research Report- Global Forecast till 2023”. Exclusive Summery About Report. ... Although there is no cure for the disease, there have been some research initiatives from pharmaceutical companies ... Reata Pharmaceuticals, Inc., Stealth BioTherapeutics, Raptor Pharmaceutical Corp., GeneDx, NeuroVive Pharmaceutical AB and others. Segmentation. ... Contact. ... Email ... ....
Increasing Prevalence of Cancer and Other Various Metabolic Diseases is Driving the Peptide Therapeutics Market
Edit Community news 22 Aug 2017
A molecule containing two or more amino acids is known as a peptide ... Growing importance of peptide therapeutics in the pharmaceutical market may significantly contribute to overall demand during the forecast period (2012 to 2020) ... Prominent companies operating in the global peptide therapeutics market are Eli Lilly and Company; Takeda Pharmaceutical Company Ltd.; Amylin Pharmaceuticals LLC; Bachem Holding AG; and Teva Pharmaceuticals....
Clinical and Regulatory Progress Boosting Biotech Sector
Edit Market Watch 22 Aug 2017
MRK, +0.78% AVEO Pharmaceuticals Inc. AVEO, +8.79% Sucampo Pharmaceuticals Inc ... , MBRX, -4.18% a preclinical pharmaceutical company focused on the development of anti-cancer drug candidates, some of which are based on license agreements with The University of Texas System on behalf of the M.D ... AVEO Pharmaceuticals Inc ... AVEO Pharmaceuticals, Inc., a biopharmaceutical company, develops targeted therapies for cancer and related diseases....
Mass Spectrometry Market Volume Forecast and Value Chain Analysis 2017-2025
Edit Community news 22 Aug 2017
Time-of-Flight (TOF) Mass Spectrometry, Orbitrap Mass Spectrometry, Quadrupole; Others ; Application Type – Pharmaceutical, Biotechnology, Industry Chemistry, Environmental Testing, Food & Beverages Testing and Others); Market Growth, Future Prospects and Competitive Analysis, 2017-2025” the market was valued at USD 5.3 Bn in 2017, and is expected to reach USD 10.5 Bn by 2025, expanding at a CAGR of 7.7% from 2017 to 2025....
J&J Enters Death Penalty Debate, Protests Use of Drug in Lethal Injection
Edit The Street 22 Aug 2017
Johnson & Johnson (JNJ) company Janssen Pharmaceuticals is opposing Florida's plan to use of one of its drugs in an upcoming execution, signaling the pharmaceutical giant's first move in the capital punishment debate, the Wall Street Journal reported ... Florida, like many states, doesn't identify its suppliers ... More of What's Trending on TheStreet ... ....
Trade Minister woos Indian investors
Edit Graphic 22 Aug 2017
“One of the parks is going to be a pharmaceutical park and we know the expertise that Indians have in this sector so we will be looking forward,”Mr Kyeremanten said ... The new pillars include; the establishment of a petrochemical industry, an iron and steel industry, an integrated aluminium industry, the expansion of the domestic production of pharmaceuticals and the establishment of a vehicle assembly and automotive industry....
Nanocellulose Market Outlook – Increasing Demand for Durable and Light Weight Materials across Industries Fueling Market Growth
Edit Community news 22 Aug 2017
In biomedicine industry, nanocellulose is used in pharmaceutical formulations in a powdered form ... Rapidly growing pharmaceuticals and packaging industries is one the major factors underpinning growth of the global nanocellulose market ... The Indian pharmaceuticals industry accounted for total revenue of US$ 31 billion in 2016....
Global cues, value buying lift equity indices
Edit Yahoo Daily News 22 Aug 2017
Healthy buying was witnessed in pharma stocks with Dr. Reddy's Laboratories, Lupin, Sun Pharmaceutical Industries and Divi's Laboratories all trading in green ... The US health regulator had carried out inspection in April ... Markets continued to trade higher with the help of the pharmaceutical sector," Dhruv Desai, Director and Chief Operating Officer of Tradebulls, told IANS. --IANS ... ....
Drug shortage
Edit Dawn 22 Aug 2017
In infants, symptoms present as vomiting, dehydration, poor feeding and weight loss ... This drug shortage, like many others of late, once again boils down to a long-standing pricing dispute between Drap and local pharmaceutical manufacturers. In its 2015 pricing policy, Drap refers to a class of pharmaceuticals exempt from the price regime. orphan drugs ... Published in Dawn, August 22nd, 2017. ....
M.A. Mortenson's $7 Billion in Active Projects Fueled by Windfarms, Enhanced by Pharma, an Industrial Info News Alert
Edit Market Watch 22 Aug 2017
SUGAR LAND, Texas, Aug ... About $5.5 billion worth already are under construction, but the list isn't limited to renewable-energy projects, which have been the company's bread and butter; it includes pharmaceutical and technological manufacturing facilities ... Details on some of Mortenson's highest-valued projects, including windfarms and pharmaceutical-manufacturing facilities in several U.S ... SOURCE Industrial Info Resources, Inc....
- 1
- 2
- 3
- 4
- 5
- Next page »
